Trulieve eyes major index uplisting as cannabis rescheduling reshapes the sector. The largest U.S. cannabis retailer is exploring a potential move from over-the-counter markets to a major exchange, a significant development that could enhance liquidity and institutional investor access. Cannabis rescheduling efforts have created tailwinds for the industry, potentially removing federal barriers that have long constrained growth and financing options. An uplisting would represent a watershed moment for Trulieve, signaling mainstream market acceptance and opening doors to broader capital sources. However, analysts maintain a cautious stance, rating the stock as a hold amid ongoing regulatory uncertainties and competitive pressures within the cannabis retail landscape.
Post from MarketNews_en
Log in to interact with content.